MoneyWorks4Me

Supriya Lifescience - Quaterly Results

21 Jan 2022 Evaluate
The Sales for the quarter ended December 2021 of Rs. 1170.00 millions rose by 45.00% from Rs. 806.91 millions.The Net Profit of the company reported a remarkable increase of 152.59% to Rs. 396.39  millions  from Rs. 156.93 millions in previous same quarter.Operating profit surged to 438.17 millions from the corresponding previous quarter of 301.58 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202112 202012 % Var
Sales 1170.00 806.91 45.00 1170.00 806.91 45.00 1170.00 806.91 45.00
Other Income 54.42 43.29 25.71 54.42 43.29 25.71 54.42 43.29 25.71
PBIDT 438.17 301.58 45.29 438.17 301.58 45.29 438.17 301.58 45.29
Interest 11.49 8.14 41.15 11.49 8.14 41.15 11.49 8.14 41.15
PBDT 426.68 293.44 45.41 426.68 293.44 45.41 426.68 293.44 45.41
Depreciation 25.99 47.91 -45.75 25.99 47.91 -45.75 25.99 47.91 -45.75
PBT 400.69 245.53 63.19 400.69 245.53 63.19 400.69 245.53 63.19
TAX 4.30 88.60 -95.15 4.30 88.60 -95.15 4.30 88.60 -95.15
Deferred Tax -119.86 3.48 -3544.25 -119.86 3.48 -3544.25 -119.86 3.48 -3544.25
PAT 396.39 156.93 152.59 396.39 156.93 152.59 396.39 156.93 152.59
Equity 160.96 146.37 9.97 160.96 146.37 9.97 160.96 146.37 9.97
PBIDTM(%) 37.45 37.37 0.20 37.45 37.37 0.20 37.45 37.37 0.20
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..